Skip to main content
OpenTrials

Clinical trial condition

Gram-Negative Bacterial Infections

Explore clinical trials studying Gram-Negative Bacterial Infections. Study availability and eligibility vary by location and protocol.

1,462 public trials 132 recruiting studies
Refine in advanced search Browse all conditions

Gram-Negative Bacterial Infections trial results

Completed

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

NCT02853929

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +37 more
Locations
  • GSK Investigational Site Carlton, Victoria, Australia
  • GSK Investigational Site Calgary, Alberta, Canada
  • GSK Investigational Site Halifax, Nova Scotia, Canada
  • GSK Investigational Site Montreal, Quebec, Canada
View all 29 locations
View Trial Details
Completed

Scrub Typhus RDT Study

NCT03269266

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations
  • No.20, 100 Bedded Military Hospital, Thabeikkyin, Mandalay Region, Burma
  • No.2, 1000 Bedded Military Hospital Nay Pyi Taw, Burma
View Trial Details
Completed

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

NCT00970307

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
Locations
  • GSK Investigational Site Bydgoszcz, Poland
  • GSK Investigational Site Dębica, Poland
  • GSK Investigational Site Krakow, Poland
  • GSK Investigational Site Krakow, Poland
View Trial Details
Completed

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

NCT00463437

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +38 more
Locations
  • GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bretten, Baden-Wurttemberg, Germany
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
View all 63 locations
View Trial Details

Related conditions